Drug factory · FDA FEI 3005503876
Charles River Endotoxin Microbial Detection Europe
9 ALLEE DU MOULIN BERGER, Ecully, France
No problems found at FDA's last inspection, Jun 5, 2024.
No Action Indicated: inspectors found no objectionable conditions.
2 drug inspections on record since 2014: 2 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Lefamulin | Tests it | Nabriva Therapeutics US, Inc. | 72000-110, 72000-120 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 5, 2024 | No problems found | Drug Quality Assurance | — |
| Mar 31, 2014 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.